Table of Contents
Do you have a routine of taking pills to control blood sugar? For many people with type 2 diabetes, Rybelsus medication seemed like a perfect solution. There is no need for needles and suffering. A simple medication brings the hope of better health.
But this hope is for some; others have serious side effects. Some of the side effects have led to the Rybelsus lawsuits. These cases are getting more attention day by day. Let’s see what Rybelsus is and what led people to file lawsuits.
Rybelsus and Its Benefits
Rybelsus is a prescription medication made by Novo Nordisk that is used in the treatment of type 2 diabetes. Rybelsus contains a drug called semaglutide, which helps the body release more insulin and reduce hunger. This can also lead to weight loss, which is helpful for some people with diabetes.
Rybelsus was the first oral GLP-1 medication approved in the U.S. It gained popularity quickly because it offered a needle-free alternative to similar injectable drugs like Ozempic and Wegovy.
Side Effects of Rybelsus
While Rybelsus has helped many people, there are also growing concerns about its side effects. Some side effects are mild, while others are more severe. This includes:
- Nausea
- Vomiting
- Diarrhea
- Constipation
- Stomach pain
These symptoms may go away, but some people have faced more dangerous health problems, such as:
- Pancreatitis: Inflammation of the pancreas and gallbladder complications have been reported, sometimes requiring surgical intervention.
- Blood clots: An increased risk of deep vein thrombosis (DVT) and pulmonary embolism (PE) has been observed in some patients.
- Gastroparesis: It causes food to stay in the stomach too long, leading to bloating, nausea, and even vomiting undigested food hours later. This condition is also known as stomach paralysis and can make daily life uncomfortable.
For some users, the health issues were so severe that they ended up in the emergency room. These experiences have pushed many to file lawsuits against Novo Nordisk.
FDA and Medical Community Response
The FDA has received several adverse event reports from patients using semaglutide medicines. But the U.S Food and Drug Administration (FDA) has not issued a formal recall of Rybelsus.
In December 2024, the FDA mandated updates to Rybelsus’s warning labels, highlighting risks such as:
- Thyroid C-cell tumor risk
- Pancreatitis
- Hypoglycemia
- Hypersensitivity
- Acute kidney injury
- Acute gallbladder disease
- Diabetic retinopathy complications
These updates were in response to the evidence of adverse effects reported by patients and healthcare providers.
In July 2023, the American Society of Anesthesiologists raised concerns about the risks of using GLP-1 drugs like Rybelsus before surgery. They found that the delayed emptying of the stomach could increase the risk of complications during anesthesia.
Some medical experts are now urging doctors to monitor patients more closely and to ask detailed questions about stomach issues while on these drugs.
Why Are People Filing Lawsuits?
People who took Rybelsus and had serious health issues are now filing lawsuits. They say the drug company, Novo Nordisk, did not give clear warnings about the possible risks.
The lawsuits claim that
- The drug caused serious health problems
- Patients were not warned about these risks
- The company may have known about the risks but did not inform
As of now, many people across the U.S. have filed lawsuits against Novo Nordisk. The main goal of the lawsuits is to get compensation for medical costs, pain, and other losses. Some people needed surgery or long hospital stays because of the side effects. Others may need lifelong care.
If someone took Rybelsus and experienced serious digestive or stomach problems, they might be eligible to file a Rybelsus lawsuit.
Rybelsus Lawsuit Update 2025
Lawsuits involving Rybelsus and other semaglutide drugs are being consolidated into multidistrict litigation (MDL). The MDL is currently in the early stages, focusing on gathering evidence and deciding how the cases should move forward.
How To File A Rybelsus Lawsuit?
If you believe Rybelsus has caused you serious health problems, you may be able to file a lawsuit. Here’s a simple list of how the process usually works:
- Eligibility check
Start by speaking with a lawyer who handles drug-related cases. They can help you understand if you have a valid case.
- Collect evidence
To build a strong case, you’ll need proof. This may include your medical records, bills, prescriptions, and reports from doctors or experts.
- File the lawsuit
Your lawyer will file the lawsuit and make sure it’s done within the time limit set by law.
- Negotiations or trial
In many cases, lawyers try to settle with the drug company before going to court. If no agreement is reached, your case might go to trial.
Having an experienced Rybelsus lawsuit lawyer by your side makes the process easier and can improve your chances of getting fair compensation.
To wrap up,
Rybelsus has provided benefits to many managing type 2 diabetes, but the emergence of serious side effects has led to lawsuits. Patients are encouraged to consult healthcare professionals regarding any adverse symptoms and to seek legal counsel if they believe they have been affected.
